Literature DB >> 1692115

Endometrial carcinoma in five patients with breast cancer on tamoxifen therapy.

A Mathew1, A B Chabon, B Kabakow, M Drucker, R J Hirschman.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1692115

Source DB:  PubMed          Journal:  N Y State J Med        ISSN: 0028-7628


× No keyword cloud information.
  8 in total

1.  Suppression of Estrogenic Activity by Medroxyprogesterone Acetate in Tamoxifen-treated Patients after Surgery for Breast Cancer to Reduce the Risk of Endometrial Cancer Development.

Authors: 
Journal:  Breast Cancer       Date:  1996-03-29       Impact factor: 4.239

Review 2.  Tamoxifen: a review of pharmacoeconomic and quality-of-life considerations for its use as adjuvant therapy in women with breast cancer.

Authors:  H M Bryson; G L Plosker
Journal:  Pharmacoeconomics       Date:  1993-07       Impact factor: 4.981

3.  Tamoxifen and cancer of the endometrium.

Authors:  G O'Connell; A Arnold
Journal:  CMAJ       Date:  1993-06-15       Impact factor: 8.262

4.  The effect of tamoxifen on the endometrium.

Authors:  B Uziely; A Lewin; G Brufman; D Dorembus; S Mor-Yosef
Journal:  Breast Cancer Res Treat       Date:  1993       Impact factor: 4.872

Review 5.  What do we know and what don't we know about tamoxifen in the human uterus.

Authors:  A Friedl; V C Jordan
Journal:  Breast Cancer Res Treat       Date:  1994       Impact factor: 4.872

Review 6.  A risk-benefit assessment of tamoxifen therapy.

Authors:  W H Catherino; V C Jordan
Journal:  Drug Saf       Date:  1993-05       Impact factor: 5.606

7.  Endometrial evaluation by ultrasonography, hysteroscopy and histopathology in cases of breast carcinoma on Tamoxifen therapy.

Authors:  Alka Jindal; Manjit K Mohi; Manjeet Kaur; Balwinder Kaur; Risham Singla; Shaunik Singh
Journal:  J Midlife Health       Date:  2015 Apr-Jun

8.  The occurrence of invasive cancers following a diagnosis of breast carcinoma in situ.

Authors:  D Robinson; L Holmberg; H Møller
Journal:  Br J Cancer       Date:  2008-07-29       Impact factor: 7.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.